Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Manchester United A | MANU | Nov 27, 2024 | 17.03 | +0.53 |
Mangoceuticals | MGRX | Nov 27, 2024 | 2.53 | +1.82 |
Manhattan Associates | MANH | Nov 27, 2024 | 287.68 | -0.44 |
Manhattan Bridge Capital | LOAN | Nov 27, 2024 | 5.36 | +1.52 |
Manitex International | MNTX | Nov 27, 2024 | 5.73 | 0.00 |
Manitowoc | MTW | Nov 27, 2024 | 10.63 | +0.66 |
Mannatech | MTEX | Nov 27, 2024 | 7.86 | 0.00 |
MannKind | MNKD | Nov 27, 2024 | 6.61 | +0.46 |
ManpowerGroup | MAN | Nov 27, 2024 | 64.56 | +0.65 |
Manulife Financial | MFC | Nov 27, 2024 | 31.89 | +0.13 |
Maplebear | CART | Nov 27, 2024 | 43.44 | -0.23 |
Marathon Digital | MARA | Nov 27, 2024 | 26.92 | +7.81 |
Marathon Oil | MRO | Nov 27, 2024 | 28.55 | 0.00 |
Marathon Petroleum | MPC | Nov 27, 2024 | 155.36 | -1.13 |
Maravai LifeSciences A | MRVI | Nov 27, 2024 | 5.92 | +5.34 |
Marblegate Acquisition A | GATE | Nov 27, 2024 | 11.13 | 0.00 |
Marchex B | MCHX | Nov 27, 2024 | 1.86 | +7.51 |
Marcus | MCS | Nov 27, 2024 | 22.48 | +2.55 |
Marcus & Millichap | MMI | Nov 27, 2024 | 41.91 | +0.02 |
Marex Group | MRX | Nov 27, 2024 | 29.15 | -0.21 |
Marin Software | MRIN | Nov 27, 2024 | 2.28 | -1.06 |
Marine Petroleum Trust U | MARPS | Nov 27, 2024 | 4.04 | +1.64 |
Marine Products | MPX | Nov 27, 2024 | 9.86 | -1.50 |
MarineMax | HZO | Nov 27, 2024 | 32.52 | +1.12 |
Marinus Pharmaceuticals | MRNS | Nov 27, 2024 | 0.32 | +0.93 |
Maris-Tech | MTEK | Nov 27, 2024 | 2.10 | -5.41 |
Markel | MKL | Nov 27, 2024 | 1 785.11 | +0.53 |
Marker Therapeutics | MRKR | Nov 27, 2024 | 3.19 | -2.15 |
Market Vectors Bdc Income ETF | BIZD | Nov 27, 2024 | 16.80 | +0.48 |
Market Vectors Investment Grade | FLTR | Nov 27, 2024 | 25.52 | +0.04 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.